首页> 外国专利> new compounds of carbon dioxide - mineral salt type i and ii of the procains and derived analogues, their production and stabilization method for targeted local and systemic pharmaceutical applications

new compounds of carbon dioxide - mineral salt type i and ii of the procains and derived analogues, their production and stabilization method for targeted local and systemic pharmaceutical applications

机译:二氧化碳的新化合物-普鲁卡因及其衍生类似物的i和ii型矿物盐,其生产和稳定化方法,用于有针对性的局部和全身性药物应用

摘要

the subject of this patent application are new compounds of carbon dioxide - mineral salt type of procains and derived stable analogues as cyclic polymers (oil and trimere) of type i and in dilute solution by kohlensu00e4urezusatz stabilized monomerer type iiwhat (= hydrogen or deuterium to understand and x = f, cl, br or h meansprocedures to arzneimittelgerechten manufacture as mediators for human and veterinary pharmaceutical applications, local and systemic, the actual substance, some procaine or some procainanaloga under physiologically adapted on-site conditions without prior metabolism to de a target transport.the erfindungsgemu00e4u00dfen compounds have the ability to barriers such as the skin, intestine and cell membranes to happen and their pharmaceutical effect than pain, anti-inflammatory and immunomodulatory agents with good tolerance in systemic and local applications to unfold. the physiological adaptation of the active substance and carbon dioxide - procain orprocainanaloges base pair is a significant wirkstoffeinsparung allows, not least by the carrierwirkung of carbonic acid and its salts is guaranteed.11medicine, neuraltherapeuten, enzymatic fission productsthrough the use of a new substance specific approach, a new way, a narrow path for the stable and metastable molecules to identify, to their production, which has not yet been possible to ensure the was. it was working with a surplus.2and a defined amount of water (carbonated water) and the presence of a mineralsalzes as nacl, through which the reaktionsgleichgewicht significantly in favour of the target products could be drawn. the main reasons for this specific reaction is the fact that a surplus.2in both concentrated and diluted medication a drift in the acid range without decomposition of the hydrogencarbonats allows. this is on the one hand, for compounds of type i and type ii are used.from the solid type i may be located using dilute carbonic acid injection and infusion solutions of type ii for the effective, more effective and acceptable. carbon dioxide - salts of type i and type ii are equally excellent.
机译:本专利申请的主题是二氧化碳的新型化合物-普鲁卡因的矿物盐型和衍生的稳定型类似物,如i型环状聚合物(油和三丁烯),并在稀释溶液中由kohlens u00e4urezusatz稳定型II型单体形成什么(=理解的氢或氘,x = f,cl,br或h表示在生理适应性现场条件下,无需事先代谢即可转移至人和兽药应用介质,局部和全身,实际物质,某些普鲁卡因或某些普鲁卡因类似物的过程,而无需事先进行代谢以达到目标转运的目的。erfindungsgem u00e4 u00dfen化合物具有与皮肤,肠和细胞膜等屏障发生作用的能力及其药理作用比止痛,抗炎和免疫调节剂在全身和局部应用中具有良好的耐受性得以展现。活性物质和二氧化碳的生理适应性-普鲁卡因或procainanaloges碱基对是重要的wirkstoffeinsparung允许的,尤其是通过碳酸及其盐的载体得以保证。1个1个药物,神经治疗药,酶促裂变产品通过使用一种新的特定于物质的方法,一种新方法,一条稳定和亚稳分子鉴定其生产的狭窄途径,这尚无法确保。它有盈余。2以及一定量的水(碳酸水)和矿物质盐(如氯化钠)的存在,可以通过该萃取物显着促进目标产物的生成。做出这种具体反应的主要原因是存在盈余。2在浓缩和稀释药物中,酸范围内的漂移都不会使碳酸氢盐分解。一方面,对于类型为i和类型ii的化合物。为了有效,更有效和可接受,可以使用类型ii的稀碳酸注入和输注溶液从固体类型i中定位。二氧化碳-i型和ii型盐同样出色。

著录项

  • 公开/公告号DE102013015035A1

    专利类型

  • 公开/公告日2015-04-02

    原文格式PDF

  • 申请/专利权人 HELMUT KASCH;

    申请/专利号DE102013015035A1

  • 发明设计人 GLEICH ANMELDER;

    申请日2013-09-02

  • 分类号A61K31/245;A61P25/28;A61P11/16;A61P29/00;A61P35/00;

  • 国家 DE

  • 入库时间 2022-08-21 14:55:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号